International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

Meet our Newest Councilors

We are thrilled to announce our newest IPC Councilors for 2023 and extend a warm welcome to José Manuel Carrascosa, Xiang Chen, Álvaro González-Cantero, Emmanuel Mahé, Yuling Shi, Liangdan Sun, Alex Tsoi, and Margarita Velásquez. The IPC Board of Directors confirmed these impressive individuals in March for their unwavering dedication to psoriasis and their unrelenting commitment to improving patient care for psoriasis patients across the globe.

As IPC Councilors, these experts will serve as trusted advisors, lending their invaluable global expertise on psoriasis research, treatment, and education to support all IPC programs, events, and initiatives.

We invite you to learn more about our newest Councilors and their extensive backgrounds by reading their biographies. We are confident that their contributions will help further our mission to advance psoriasis care globally.

José-Manuel Carrascosa Carrillo, MD, PhD

University Hospital Germans Trias í Pujol; Autonomous University of Barcelona

Badalona, Spain


Xiang Chen, MD, PhD

Dept. Dermatology, Xiangya Hospital, Central South

Changsha, China


Álvaro González-Cantero, MD, PhD

Hospital Ramón y Cajal University Hospital

Madrid, Spain


Emmanuel Mahé , MD, PhD

Hôspital Victor Dupouy

Argenteuil, France


Yuling Shi, MD, PhD

Shanghai Skin Disease Hospital, Tongji University School of Medicine

Shanghai, China


Liangdan Sun, MD, PhD

Health Science Center of North China University of Science and Technology

Hebei Province, China


Alex Tsoi, MS, PhD

University of Michigan

Ann Arbor, Michigan, United States


Margarita María Velásquez Lopera, PhD

University of Antioquia

Medellín, Colombia


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.


Recent Posts

New IPC Guidelines on Generalized Pustular Psoriasis

Commentary: An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis

Introducing our Latest IPC Councilors: Experts in Psoriasis Treatment and Research

Also Read

Generalized Pustular Psoriasis

New IPC Guidelines on Generalized Pustular Psoriasis

Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the essential features, the importance of accurate diagnosis, and the expected global impact on patient care.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.